Mary McDermott, MD, professor in general internal medicine and geriatrics and preventive medicine, recently published a study in JAMA that may change clinical guidelines for patients with peripheral artery disease (PAD).
To hone critical thinking and investigational skills, rising second-year students conduct research projects over the summer as part of the new curriculum. Two students share their work in basic science.
While it’s long been known that oxytocin promotes feelings of love, social bonding, and wellbeing, only recently have scientists discovered it’s link to anxiety-producing bad memories.
A graduate of Northwestern’s Honors Program in Medical Education, Rear Admiral Boris Lushniak, MD ’83, MPH, became acting surgeon general of the United States on July 17.
Published in Anesthesiology, Eugene Silinsky, PhD, has found that calcium channels, and not a depletion of neurotransmitters as previously thought, are responsible for the decreased response in muscles treated by neuromuscular blockers. The finding could prove helpful in developing new therapies for a host of neuromuscular diseases.
Program will integrate training in mental healthcare for LGBT clients with rotations in an infectious disease clinic and more.
Five Northwestern University Feinberg School of Medicine faculty members were accepted into the 2013-14 Searle Fellows Program, a year-long faculty development program.
In the first step toward animal-to-human transplants of insulin-producing cells for people with type 1 diabetes, Northwestern Medicine® scientists have successfully transplanted islets, the cells that produce insulin, from one species to another. And the islets survived without immunosuppressive drugs.
Published in the Journal of the American Medical Association, scientists determined that patients with coronary artery disease and regional myocardial wall thinning often have only limited scarring.
The Research on Adverse Drug Events and Reports project issued reports on 33 serious adverse drug or device reactions in its first decade of existence, showing its value as an independent drug surveillance program.